U.S. Markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.09
    +0.45 (+0.99%)
     
  • Gold

    1,837.70
    +0.90 (+0.05%)
     
  • Silver

    24.32
    +0.18 (+0.76%)
     
  • EUR/USD

    1.2127
    -0.0022 (-0.1819%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • Vix

    20.79
    -0.49 (-2.30%)
     
  • GBP/USD

    1.3438
    -0.0015 (-0.1088%)
     
  • USD/JPY

    104.1400
    +0.2800 (+0.2696%)
     
  • BTC-USD

    19,124.33
    +76.04 (+0.40%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Chinook Therapeutics Inc (KDNY) President, CEO Eric Dobmeier Bought $62,100 of Shares

GuruFocus.com
·1 min read

- By insider

President, CEO of Chinook Therapeutics Inc (30-Year Financial, Insider Trades) Eric Dobmeier (insider trades) bought 4,500 shares of KDNY on 11/11/2020 at an average price of $13.8 a share. The total cost of this purchase was $62,100.


Chinook Therapeutics Inc has a market cap of $608.340 million; its shares were traded at around $14.43 with and P/S ratio of 17.83. GuruFocus has detected 1 severe warning sign with Chinook Therapeutics Inc. .

CEO Recent Trades:

  • President, CEO Eric Dobmeier bought 4,500 shares of KDNY stock on 11/11/2020 at the average price of $13.8. The price of the stock has increased by 4.57% since.

For the complete insider trading history of KDNY, click here

.This article first appeared on GuruFocus.